CluePoints Newsroom

Serving up the latest news and information about CluePoints

View all of our News Articles
June 21, 2022 in Uncategorized

CluePoints to Share Case Study on Technology ROI at The SCDM 2022 EMEA Leadership Forum & Conference

Decentralized clinical trials (DCTs) have become a buzzphrase in recent years, with commentators lining up to extol the benefits of this new way of working.…
Read More
June 16, 2022 in Uncategorized

Join us at DIA 2022 as we Demystify the De-risking of DCTs

The world of decentralized clinical trials (DCTs) and risk-based quality management is evolving rapidly – but CluePoints and our partners are here to help you…
Read More
June 1, 2022 in Blog, COVID-19, Data Quality Assessment

10 Ways the Pandemic Changed CluePoints

Author: Patrick Hughes, Co-Founder & Chief Commercial Officer, CluePoints As CluePoints celebrates ten years as the leading provider of Risk-Based Study Execution (RBx) and Risk-Based…
Read More
April 20, 2022 in Blog, Data Quality Assessment

10 Ways Mid-Sized BioPharma Has Applied a Pragmatic Approach to RBQM Implementation

Author: Dan Beaudry, Senior Vice President, Customer Success As the shift towards decentralized clinical trials accelerates, powered by the COVID-19 pandemic as well as the…
Read More
April 20, 2022 in Blog, Centralized Monitoring

Does Central Monitoring Lead to Higher Quality? An Analysis of KRI Outcomes

Author: Sylviane de Viron, Manager, Data & Knowledge, CluePoints and William Steijn, Research Data Analyst, CluePoints Central Monitoring is a key component of Risk-Based Quality…
Read More
April 11, 2022 in Blog, events

CluePoints Co-Founder and Chief Executive Officer to Speak at SCOPE Europe

Francois Torche, Co-Founder and Chief Executive Officer at CluePoints, will share insights into utilizing Risk-Based Quality Management (RBQM) to improve trial outcomes at this year’s…
Read More
April 11, 2022 in Blog, Data Quality Assessment

FDA Places Quality Management at the Heart of Updated Inspection Guide

Author: Patrick Hughes, Co-Founder & Chief Commercial Officer, CluePoints It's official: Risk-Based Quality Management (RBQM) is essential for the smooth running of clinical trials. The…
Read More
April 11, 2022 in Awards, Blog, News

CluePoints Wins Citeline Award for Excellence in Innovation in Response to COVID-19 – Clinical Trial Activities

Company wins prestigious accolade for contribution to Pfizer/BioNTech BNT162b2 COVID-19 vaccine development King of Prussia, PA  – April 11, 2022: CluePoints, the premier provider of Risk-Based Study Execution (RBx)…
Read More
April 7, 2022 in Blog, Blogs in Japanese, Trial Assurance


CluePoints社EMEA & APA SVP担当であるJohn Hallが、分散型臨床試験の成長を促進する市場要因と、この機会を完全に捉えるために取り除く必要のある障害について詳しく説明いたします。
Read More
April 5, 2022 in Blog, News

CluePoints Continues Impressive Global Growth with Three New Senior Appointments

The company welcomes new VP Marketing, VP People, and VP Business Operations to its expanding team King of Prussia, PA  – April 5, 2022: CluePoints, the premier…
Read More


Find out where we’re headed next.

Featured Whitepaper

ICH E6 (R2)

Created in conjunction with our peers at TUFTS Center for the Study of Drug Development, this paper provides insights on how companies are responding to ICH E6 (R2) and information on the key themes on adoption.

Learn More

Featured Webinar

ICH E6 (R2)

This recorded webinar covers all of the frequently asked Questions about ICH E6 (R2), Risk-Based Study Execution (RBx) and what’s required from a people, process & technology standpoint.

Learn More

We're Kind of a Big Deal.


Platform Users


Studies De-Risked


Issues Detected